Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma
- PMID: 16969481
Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma
Abstract
Vasculogenic mimicry (VM) has increasingly been recognized as a form of angiogenesis. In VM, epithelial cells are integrated into the malignant tumor vasculature. An association has been observed between VM and poor clinical prognosis in some malignant tumors. However, whether VM is present and clinically significant in hepatocellular carcinoma (HCC) is unknown. In this study, we determined whether VM was present in HCC and whether it was associated with tumor grade, invasion and metastasis, and survival duration. We collected paraffin-embedded HCC tumor samples, along with complete clinical and pathologic data for all the cases, and performed immunohistochemical staining for CD31, CD105 (endoglin), hepatocyte, vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9. The VM status was compared with the clinical and pathological data using statistical tests. Kaplan-Meier survival analysis and log-rank test were used to compare survival durations between patients with and without VM. The VM vessel cells were CD31 and CD105-negative and hepatocyte and vascular endothelial growth factor-positive, showing that they were not derived from endothelial cells but were HCC tumor cells. Patients with VM had a higher metastasis rate than did those without VM (P=0.003). Consistent with this finding, MMP-2 and MMP-9 were present in all the VM cases but were found less frequently in non-VM cases (P<0.05). The Kaplan-Meier survival analysis showed that patients in the VM group had a significantly shorter survival duration than did those in the non-VM group. In conclusion, VM is a marker of poor clinical prognosis in HCC: Its presence may be associated with a high tumor grade, invasion and metastasis, and short survival.
Similar articles
-
[A study on vasculogenic mimicry in hepatocellular carcinoma].Zhonghua Gan Zang Bing Za Zhi. 2006 Jan;14(1):41-4. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16420764 Chinese.
-
Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors.Hum Pathol. 2008 Mar;39(3):444-51. doi: 10.1016/j.humpath.2007.07.018. Hum Pathol. 2008. PMID: 18261629
-
Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.Liver Transpl. 2010 May;16(5):621-30. doi: 10.1002/lt.22028. Liver Transpl. 2010. PMID: 20440771
-
Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.Pharmacol Res. 2021 Apr;166:105507. doi: 10.1016/j.phrs.2021.105507. Epub 2021 Feb 18. Pharmacol Res. 2021. PMID: 33610718 Review.
-
[Vasculogenic mimicry--potential target for tumor therapy].Ai Zheng. 2006 Jul;25(7):914-6. Ai Zheng. 2006. PMID: 16831290 Review. Chinese.
Cited by
-
Polyploid giant cancer cell characterization: New frontiers in predicting response to chemotherapy in breast cancer.Semin Cancer Biol. 2022 Jun;81:220-231. doi: 10.1016/j.semcancer.2021.03.017. Epub 2021 Mar 22. Semin Cancer Biol. 2022. PMID: 33766651 Free PMC article. Review.
-
A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma.Arch Pathol Lab Med. 2007 Dec;131(12):1776-81. doi: 10.5858/2007-131-1776-APSOVM. Arch Pathol Lab Med. 2007. PMID: 18081435 Free PMC article.
-
RIPK1-dependent necroptosis promotes vasculogenic mimicry formation via eIF4E in triple-negative breast cancer.Cell Death Dis. 2023 May 22;14(5):335. doi: 10.1038/s41419-023-05841-w. Cell Death Dis. 2023. PMID: 37217473 Free PMC article.
-
Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors.Front Oncol. 2019 Dec 19;9:1445. doi: 10.3389/fonc.2019.01445. eCollection 2019. Front Oncol. 2019. PMID: 31921690 Free PMC article.
-
Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma.J Exp Clin Cancer Res. 2008 Nov 4;27(1):60. doi: 10.1186/1756-9966-27-60. J Exp Clin Cancer Res. 2008. PMID: 18983651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous